Patients receive gemcitabine toxicity epirubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Cell Line, Tumor Tumor Cells, Cultured

Organisms1

Diseases32

Pancreatic Neoplasms Breast Neoplasms Biliary Tract Neoplasms Adenocarcinoma Neutropenia Lung Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Leukopenia Nausea Hematologic Diseases Neoplasms Vomiting Disease Progression Alopecia Carcinoma, Pancreatic Ductal Carcinoma, Transitional Cell Urinary Bladder Neoplasms Stomatitis Neoplasm Recurrence, Local Thrombocytopenia Urologic Neoplasms Carcinoma Gallbladder Neoplasms Stomach Neoplasms Liver Neoplasms Soft Tissue Neoplasms Sarcoma Ovarian Neoplasms Lymphatic Metastasis Bone Neoplasms Heart Diseases

Chemicals and Drugs44

Epirubicin Deoxycytidine Antimetabolites, Antineoplastic Antibiotics, Antineoplastic Fluorouracil Cisplatin Paclitaxel Taxoids Cyclophosphamide Deoxycytidine Kinase Vinblastine Antineoplastic Agents Doxorubicin Razoxane Carboplatin Anthracyclines Equilibrative Nucleoside Transporter 1 Organoplatinum Compounds Granulocyte Colony-Stimulating Factor Ifosfamide Methotrexate Antineoplastic Agents, Phytogenic Lead Radioisotopes Radiation-Sensitizing Agents Ribonucleoside Diphosphate Reductase Etoposide Antibodies, Monoclonal, Humanized CA-19-9 Antigen Tegafur Camptothecin Prolyl Hydroxylases Leucovorin Guanine Quinazolines Receptor, erbB-2 Glutamates Antibodies, Monoclonal Ribonucleotide Reductases Oxonic Acid Antineoplastic Agents, Alkylating Mitoxantrone Naphthacenes Vincristine Floxuridine

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Disease-Free Survival Toxicity Tests Maximum Tolerated Dose Chemotherapy, Adjuvant Survival Rate Combined Modality Therapy Neoadjuvant Therapy Neoplasm Staging Toxicity Tests, Acute Survival Analysis Xenograft Model Antitumor Assays Kaplan-Meier Estimate Area Under Curve Follow-Up Studies Injections, Intravenous Prognosis Drug Screening Assays, Antitumor Remission Induction Inhibitory Concentration 50 Drug Evaluation Administration, Oral Salvage Therapy Feasibility Studies Prospective Studies Administration, Intravesical Infusions, Intra-Arterial Tumor Burden Lethal Dose 50 Palliative Care

Phenomena and Processes13

Dose-Response Relationship, Drug Maximum Tolerated Dose Drug Resistance, Neoplasm Drug Synergism Time Factors Apoptosis Cell Survival Area Under Curve Drug Interactions Inhibitory Concentration 50 Cell Proliferation Lethal Dose 50 Drug Resistance, Multiple

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science1

Health Care10

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Kaplan-Meier Estimate Area Under Curve Follow-Up Studies Feasibility Studies Prospective Studies Palliative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Epirubicin Deoxycytidine Antimetabolites, Antineoplastic Antineoplastic Combined Chemotherapy Protocols Pancreatic Neoplasms Drug Administration Schedule Antibiotics, Antineoplastic Fluorouracil Cisplatin Paclitaxel Taxoids Treatment Outcome Breast Neoplasms Cyclophosphamide Infusions, Intravenous Deoxycytidine Kinase Vinblastine Dose-Response Relationship, Drug Disease-Free Survival Biliary Tract Neoplasms Toxicity Tests Maximum Tolerated Dose Adenocarcinoma Chemotherapy, Adjuvant Neutropenia Antineoplastic Agents Lung Neoplasms Doxorubicin Survival Rate Drug Resistance, Neoplasm Combined Modality Therapy Razoxane Carboplatin Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Neoadjuvant Therapy Leukopenia Neoplasm Staging Cell Line, Tumor Anthracyclines Drug Synergism Nausea Equilibrative Nucleoside Transporter 1 Hematologic Diseases Organoplatinum Compounds Granulocyte Colony-Stimulating Factor Toxicity Tests, Acute Ifosfamide Neoplasms Methotrexate Vomiting Antineoplastic Agents, Phytogenic Disease Progression Alopecia Survival Analysis Carcinoma, Pancreatic Ductal Carcinoma, Transitional Cell Urinary Bladder Neoplasms Stomatitis Xenograft Model Antitumor Assays Time Factors Lead Radioisotopes Radiation-Sensitizing Agents Neoplasm Recurrence, Local Ribonucleoside Diphosphate Reductase Etoposide Thrombocytopenia Apoptosis Kaplan-Meier Estimate Cell Survival Urologic Neoplasms Area Under Curve Mice, Nude Antibodies, Monoclonal, Humanized CA-19-9 Antigen Drug Interactions Tegafur Follow-Up Studies Camptothecin Injections, Intravenous Prolyl Hydroxylases Prognosis Leucovorin Drug Screening Assays, Antitumor Carcinoma Guanine Remission Induction Inhibitory Concentration 50 Drug Evaluation Quinazolines Receptor, erbB-2 Administration, Oral Gallbladder Neoplasms Stomach Neoplasms Glutamates Salvage Therapy Liver Neoplasms Antibodies, Monoclonal Soft Tissue Neoplasms Ribonucleotide Reductases

No FAQ available that match "patients receive gemcitabine toxicity epirubicin"